| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 3e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |